全球呼吸系统诊断市场

预计到2030年，全球呼吸系统诊断市场规模将达98亿美元。

全球呼吸系统诊断市场预计在2024年达到76亿美元，预计2030年将达到98亿美元，在分析期间（2024-2030年）内复合年增长率（CAGR）为4.5%。本报告分析的细分市场之一－仪器和设备细分市场，预计在分析期间结束时将以4.5%的复合年增长率成长，达到51亿美元。试剂盒和试剂细分市场预计在分析期内将以4.9%的复合年增长率成长。

美国市场规模估计为20亿美元，而中国市场预计将以7.4%的复合年增长率成长。

美国呼吸系统诊断市场预计2024年规模将达到20亿美元。作为世界第二大经济体，中国预计到2030年市场规模将达到21亿美元，在2024年至2030年的分析期间内，复合年增长率（CAGR）将达到7.4%。其他值得关注的区域市场分析包括日本和加拿大，预计在分析期内，这两个市场的复合年增长率将分别达到2.3%和3.6%。在欧洲，德国的复合年增长率预计将达到约2.9%。

全球呼吸系统诊断市场—主要趋势与驱动因素概述

呼吸系统诊断：推进肺部疾病检测

呼吸系统诊断技术透过提供更精准、非侵入性、快速的检测方法，正在革新肺部疾病的检测和管理。这些诊断技术涵盖多种检测手段，包括肺功能测试（肺活量测定）、血液气体分析和影像学检查，用于评估肺功能并检测结核病、气喘、慢性阻塞性肺病（COPD）和肺部感染疾病等疾病。早期发现呼吸系统疾病对于有效治疗和管理至关重要，因为许多此类疾病若不及时治疗，可能导致严重的併发症。诊断技术的进步使医疗专业人员能够更精准地诊断呼吸系统疾病，从而改善患者的治疗效果，并提高患者的生活品质。

哪些技术进步正在改善呼吸系统诊断？

技术创新显着提升了呼吸系统诊断能力，使其更加精准、便利且易于使用。高解析度电脑断层扫描（HRCT）和磁振造影（MRI）等影像技术的进步，使得肺部结构的精细可视化成为可能，并能早期发现标准X光片无法显示的疾病。此外，携带式照护现场诊断设备（如携带式肺计量计和脉动式血氧监测仪系统）的研发，也使得医护人员能够在包括诊所和患者家中在内的各种环境下轻鬆进行检测。聚合酵素链锁反应（PCR）和次世代定序（NGS）等分子诊断技术的进步，也提高了我们检测特定病原体和与呼吸系统疾病相关的遗传标记的能力。这些技术创新促进了呼吸系统诊断的广泛应用，从而能够对肺部健康进行更全面、更准确的评估。

呼吸系统诊断的主要用途和益处是什么？

呼吸系统诊断广泛应用于各种临床场景，用于评估肺功能、诊断呼吸系统疾病以及监测治疗效果。在基层医疗中，肺活量测定法是一种常用的诊断工具，用于测量肺容量和气流，有助于诊断气喘和慢性阻塞性肺病（COPD）等疾病。在医院，更先进的检测方法，例如血液气体分析和高解析度电脑断层扫描，用于评估呼吸系统疾病的严重程度并指南治疗决策。分子诊断在呼吸系统检测中的应用日益重要，尤其是在识别引起呼吸道感染疾病的特定病原体和实现标靶治疗。呼吸系统诊断的主要优点包括更早发现肺部疾病、提高诊断准确性以及更好地监测疾病进展和治疗效果。这些优势使呼吸系统诊断成为现代医学的重要组成部分，有助于改善患者照护和疾病管理。

哪些因素正在推动呼吸系统诊断市场的成长？

呼吸系统诊断市场的成长受多种因素驱动。气喘、慢性阻塞性肺病（COPD）和肺部感染疾病等呼吸系统疾病的日益普遍是关键驱动因素，因为它增加了对准确可靠诊断工具的需求。技术进步，特别是影像学、分子诊断和照护现场设备领域的进步，也透过提高呼吸系统诊断的能力和可近性来推动市场成长。人们日益认识到早期发现和管理呼吸系统疾病的重要性，进一步推动了对这些诊断方法的需求，因为早期疗育可以预防併发症并改善患者预后。此外，新冠肺炎疫情的持续影响凸显了有效呼吸系统诊断的重要性，刺激了该领域的进一步投资和创新。这些因素，加上医疗技术的不断进步，正在推动呼吸系统诊断市场的持续成长。

部分：

服务（仪器/设备、试剂盒/试剂、服务/软体）、检测类型（机械检测、影像检查、分子诊断检测、其他检测）、疾病类型（结核病、气喘、慢性阻塞性肺病、其他疾病）

受访公司范例

• Abbott Laboratories
• Alere, Inc.
• Becton, Dickinson and Company
• bioMerieux SA
• Bio-Rad Laboratories, Inc.
• Cosmed Srl
• Philips Healthcare
• SDI Diagnostics
• Seegene, Inc.
• Thermo Fisher Scientific, Inc.

人工智慧集成

我们正在利用检验的专家内容和人工智慧工具，改变您分析市场和竞争情报的方式。

Market Glass, Inc. 并没有查询LLM 或产业专用的SLM 的典型方法，而是建立了一个由世界各地领域专家精心策划的内容库，其中包括视频转录、博客、搜寻引擎研究以及大量的公司、产品/服务和市场数据。

关税影响係数

在最新发布的报告中，Market Glass, Inc. 将关税对地理市场的影响纳入考量，并根据公司总部所在地、製造地以及进出口（成品和OEM产品）情况，预测企业竞争地位的变化。这种复杂多变的市场现实会从多个方面影响竞争对手，包括增加销货成本、降低盈利和重组供应链，同时也会影响微观和宏观市场动态。

目录

第一章调查方法

第二章执行摘要

• 市场概览
• 主要企业
• 市场趋势和驱动因素
• 全球市场展望

第三章 市场分析

• 美国
• 加拿大
• 日本
• 中国
• 欧洲
• 法国
• 德国
• 义大利
• 英国
• 西班牙
• 俄罗斯
• 其他欧洲
• 亚太地区
• 澳洲
• 印度
• 韩国
• 亚太其他地区
• 拉丁美洲
• 阿根廷
• 巴西
• 墨西哥
• 其他拉丁美洲
• 中东
• 伊朗
• 以色列
• 沙乌地阿拉伯
• 阿拉伯聯合大公国
• 其他中东地区
• 非洲

第四章 竞赛

Global Respiratory Diagnostics Market to Reach US$9.8 Billion by 2030

The global market for Respiratory Diagnostics estimated at US$7.6 Billion in the year 2024, is expected to reach US$9.8 Billion by 2030, growing at a CAGR of 4.5% over the analysis period 2024-2030. Instruments & Devices, one of the segments analyzed in the report, is expected to record a 4.5% CAGR and reach US$5.1 Billion by the end of the analysis period. Growth in the Kits & Reagents segment is estimated at 4.9% CAGR over the analysis period.

The U.S. Market is Estimated at US$2.0 Billion While China is Forecast to Grow at 7.4% CAGR

The Respiratory Diagnostics market in the U.S. is estimated at US$2.0 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$2.1 Billion by the year 2030 trailing a CAGR of 7.4% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.3% and 3.6% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.9% CAGR.

Global Respiratory Diagnostics Market - Key Trends and Drivers Summarized

Respiratory Diagnostics: Advancing the Detection of Lung Diseases

Respiratory diagnostics are revolutionizing the detection and management of lung diseases by providing more accurate, non-invasive, and rapid testing methods. These diagnostics encompass a range of tests, including spirometry, blood gas analysis, and imaging techniques, that assess lung function and detect conditions such as tuberculosis, asthma, chronic obstructive pulmonary disease (COPD), and lung infections. Early detection of respiratory diseases is crucial for effective treatment and management, as many of these conditions can lead to severe complications if left untreated. With advancements in diagnostic technology, healthcare providers can now diagnose respiratory conditions with greater precision, leading to improved patient outcomes and a higher quality of life for those affected.

What Technological Advancements Are Enhancing Respiratory Diagnostics?

Technological advancements are significantly enhancing the capabilities of respiratory diagnostics, making them more accurate, accessible, and user-friendly. Innovations in imaging technology, such as high-resolution computed tomography (HRCT) and magnetic resonance imaging (MRI), allow for detailed visualization of lung structures, enabling the early detection of diseases that may not be apparent on standard X-rays. Additionally, the development of portable and point-of-care diagnostic devices, such as handheld spirometers and pulse oximeters, has made it easier for healthcare providers to conduct tests in various settings, including primary care offices and patient homes. Advances in molecular diagnostics, including polymerase chain reaction (PCR) and next-generation sequencing (NGS), have also improved the ability to detect specific pathogens and genetic markers associated with respiratory diseases. These technological innovations are driving the adoption of respiratory diagnostics, providing more comprehensive and accurate assessments of lung health.

What Are the Key Applications and Benefits of Respiratory Diagnostics?

Respiratory diagnostics are used in a wide range of clinical settings to assess lung function, diagnose respiratory diseases, and monitor treatment effectiveness. In primary care, spirometry is a common diagnostic tool used to measure lung capacity and airflow, helping to diagnose conditions like asthma and COPD. In hospitals, more advanced tests such as blood gas analysis and HRCT scans are used to assess the severity of respiratory conditions and guide treatment decisions. The use of molecular diagnostics in respiratory testing has become increasingly important, particularly in identifying the specific pathogens causing respiratory infections, enabling targeted treatment. The primary benefits of respiratory diagnostics include early detection of lung diseases, improved accuracy in diagnosis, and better monitoring of disease progression and treatment outcomes. These advantages make respiratory diagnostics a critical component of modern healthcare, supporting better patient care and disease management.

What Factors Are Driving the Growth in the Respiratory Diagnostics Market?

The growth in the Respiratory Diagnostics market is driven by several factors. The increasing prevalence of respiratory diseases, such as asthma, COPD, and lung infections, is a significant driver, as these conditions create a growing demand for accurate and reliable diagnostic tools. Technological advancements, particularly in imaging, molecular diagnostics, and point-of-care devices, are also propelling market growth by enhancing the capabilities and accessibility of respiratory diagnostics. The rising awareness of the importance of early detection and management of respiratory conditions is further boosting demand for these diagnostics, as early intervention can prevent complications and improve patient outcomes. Additionally, the ongoing impact of the COVID-19 pandemic has highlighted the critical need for effective respiratory diagnostics, driving further investment and innovation in this field. These factors, combined with the continuous advancement of medical technology, are driving the sustained growth of the Respiratory Diagnostics market.

SCOPE OF STUDY:

The report analyzes the Respiratory Diagnostics market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Offering (Instruments & Devices, Kits & Reagents, Services & Software); Test (Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests, Other Tests); Disease (Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease, Other Diseases)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 43 Featured) -

• Abbott Laboratories
• Alere, Inc.
• Becton, Dickinson and Company
• bioMerieux SA
• Bio-Rad Laboratories, Inc.
• Cosmed Srl
• Philips Healthcare
• SDI Diagnostics
• Seegene, Inc.
• Thermo Fisher Scientific, Inc.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Trade Shocks, Uncertainty, and the Structural Rewiring of the Global Economy
  • How Trump's Tariffs Impact the Market? The Big Question on Everyone's Mind
  • Global Economic Update
  • Respiratory Diagnostics: Overview & Outlook
  • Respiratory Diagnostics - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Mounting Burden of Respiratory Diseases: Major Driver
  • Pulmonary Function Test: Major Category
  • Imaging Tests Gain Traction
  • CT Screening for Improved Pulmonary Pathology
  • Bronchoscopy & Laryngoscopy for Evaluating the Airway Directly
  • Rising Cost of Medical Treatment Deters Growth
  • Rising Prevalence of Respiratory Diseases Propels Market Growth
  • Increasing Use of Diagnostic Tests in Early Detection and Disease Management Expands Addressable Market Opportunity
  • Technological Advancements in Imaging and Molecular Diagnostics Strengthen Market Position
  • Growing Focus on Personalized Medicine and Targeted Therapies Drives Adoption of Respiratory Diagnostics
  • Surge in Demand for Point-of-Care and Rapid Testing Solutions Generates New Opportunities
  • Development of Non-Invasive and Minimally Invasive Diagnostic Tools Sustains Market Growth
  • Expanding Applications in Chronic Obstructive Pulmonary Disease (COPD) and Asthma Throws Spotlight on Market Potential
  • Rising Adoption of Respiratory Diagnostics in Homecare Settings Propels Market Expansion
  • Surge in Demand for Diagnostic Solutions Amidst Global Respiratory Disease Outbreaks Expands Market Horizons
  • Growing Awareness of the Importance of Early Diagnosis in Improving Patient Outcomes Drives Market Adoption
  • Innovations in Artificial Intelligence and Machine Learning for Diagnostic Accuracy Generate New Market Opportunities
  • Rising Demand for Respiratory Diagnostics in Emerging Healthcare Markets Throws Spotlight on Market Dynamics
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Recent Past, Current & Future Analysis for Tuberculosis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 2: World Historic Review for Tuberculosis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 3: World 15-Year Perspective for Tuberculosis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 4: World Recent Past, Current & Future Analysis for Asthma by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 5: World Historic Review for Asthma by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 6: World 15-Year Perspective for Asthma by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 7: World Recent Past, Current & Future Analysis for Chronic Obstructive Pulmonary Disease by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 8: World Historic Review for Chronic Obstructive Pulmonary Disease by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 9: World 15-Year Perspective for Chronic Obstructive Pulmonary Disease by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 10: World Recent Past, Current & Future Analysis for Other Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 11: World Historic Review for Other Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 12: World 15-Year Perspective for Other Diseases by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 13: World Recent Past, Current & Future Analysis for Instruments & Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 14: World Historic Review for Instruments & Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 15: World 15-Year Perspective for Instruments & Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 16: World Recent Past, Current & Future Analysis for Kits & Reagents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 17: World Historic Review for Kits & Reagents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 18: World 15-Year Perspective for Kits & Reagents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 19: World Recent Past, Current & Future Analysis for Services & Software by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 20: World Historic Review for Services & Software by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 21: World 15-Year Perspective for Services & Software by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 22: World Recent Past, Current & Future Analysis for Mechanical Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 23: World Historic Review for Mechanical Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 24: World 15-Year Perspective for Mechanical Tests by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 25: World Recent Past, Current & Future Analysis for Imaging Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 26: World Historic Review for Imaging Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 27: World 15-Year Perspective for Imaging Tests by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 28: World Recent Past, Current & Future Analysis for Molecular Diagnostic Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 29: World Historic Review for Molecular Diagnostic Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 30: World 15-Year Perspective for Molecular Diagnostic Tests by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 31: World Recent Past, Current & Future Analysis for Other Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 32: World Historic Review for Other Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 33: World 15-Year Perspective for Other Tests by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 34: World Respiratory Diagnostics Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
  • TABLE 35: World Recent Past, Current & Future Analysis for Respiratory Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 36: World Historic Review for Respiratory Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 37: World 15-Year Perspective for Respiratory Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • Respiratory Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
  • TABLE 38: USA Recent Past, Current & Future Analysis for Respiratory Diagnostics by Disease - Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 39: USA Historic Review for Respiratory Diagnostics by Disease - Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 40: USA 15-Year Perspective for Respiratory Diagnostics by Disease - Percentage Breakdown of Value Sales for Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases for the Years 2015, 2025 & 2030
  • TABLE 41: USA Recent Past, Current & Future Analysis for Respiratory Diagnostics by Offering - Instruments & Devices, Kits & Reagents and Services & Software - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 42: USA Historic Review for Respiratory Diagnostics by Offering - Instruments & Devices, Kits & Reagents and Services & Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 43: USA 15-Year Perspective for Respiratory Diagnostics by Offering - Percentage Breakdown of Value Sales for Instruments & Devices, Kits & Reagents and Services & Software for the Years 2015, 2025 & 2030
  • TABLE 44: USA Recent Past, Current & Future Analysis for Respiratory Diagnostics by Test - Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 45: USA Historic Review for Respiratory Diagnostics by Test - Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 46: USA 15-Year Perspective for Respiratory Diagnostics by Test - Percentage Breakdown of Value Sales for Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests for the Years 2015, 2025 & 2030
• CANADA
  • TABLE 47: Canada Recent Past, Current & Future Analysis for Respiratory Diagnostics by Disease - Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 48: Canada Historic Review for Respiratory Diagnostics by Disease - Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 49: Canada 15-Year Perspective for Respiratory Diagnostics by Disease - Percentage Breakdown of Value Sales for Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases for the Years 2015, 2025 & 2030
  • TABLE 50: Canada Recent Past, Current & Future Analysis for Respiratory Diagnostics by Offering - Instruments & Devices, Kits & Reagents and Services & Software - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 51: Canada Historic Review for Respiratory Diagnostics by Offering - Instruments & Devices, Kits & Reagents and Services & Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 52: Canada 15-Year Perspective for Respiratory Diagnostics by Offering - Percentage Breakdown of Value Sales for Instruments & Devices, Kits & Reagents and Services & Software for the Years 2015, 2025 & 2030
  • TABLE 53: Canada Recent Past, Current & Future Analysis for Respiratory Diagnostics by Test - Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 54: Canada Historic Review for Respiratory Diagnostics by Test - Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 55: Canada 15-Year Perspective for Respiratory Diagnostics by Test - Percentage Breakdown of Value Sales for Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests for the Years 2015, 2025 & 2030
• JAPAN
  • Respiratory Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
  • TABLE 56: Japan Recent Past, Current & Future Analysis for Respiratory Diagnostics by Disease - Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 57: Japan Historic Review for Respiratory Diagnostics by Disease - Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 58: Japan 15-Year Perspective for Respiratory Diagnostics by Disease - Percentage Breakdown of Value Sales for Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases for the Years 2015, 2025 & 2030
  • TABLE 59: Japan Recent Past, Current & Future Analysis for Respiratory Diagnostics by Offering - Instruments & Devices, Kits & Reagents and Services & Software - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 60: Japan Historic Review for Respiratory Diagnostics by Offering - Instruments & Devices, Kits & Reagents and Services & Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 61: Japan 15-Year Perspective for Respiratory Diagnostics by Offering - Percentage Breakdown of Value Sales for Instruments & Devices, Kits & Reagents and Services & Software for the Years 2015, 2025 & 2030
  • TABLE 62: Japan Recent Past, Current & Future Analysis for Respiratory Diagnostics by Test - Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 63: Japan Historic Review for Respiratory Diagnostics by Test - Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 64: Japan 15-Year Perspective for Respiratory Diagnostics by Test - Percentage Breakdown of Value Sales for Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests for the Years 2015, 2025 & 2030
• CHINA
  • Respiratory Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
  • TABLE 65: China Recent Past, Current & Future Analysis for Respiratory Diagnostics by Disease - Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 66: China Historic Review for Respiratory Diagnostics by Disease - Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 67: China 15-Year Perspective for Respiratory Diagnostics by Disease - Percentage Breakdown of Value Sales for Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases for the Years 2015, 2025 & 2030
  • TABLE 68: China Recent Past, Current & Future Analysis for Respiratory Diagnostics by Offering - Instruments & Devices, Kits & Reagents and Services & Software - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 69: China Historic Review for Respiratory Diagnostics by Offering - Instruments & Devices, Kits & Reagents and Services & Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 70: China 15-Year Perspective for Respiratory Diagnostics by Offering - Percentage Breakdown of Value Sales for Instruments & Devices, Kits & Reagents and Services & Software for the Years 2015, 2025 & 2030
  • TABLE 71: China Recent Past, Current & Future Analysis for Respiratory Diagnostics by Test - Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 72: China Historic Review for Respiratory Diagnostics by Test - Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 73: China 15-Year Perspective for Respiratory Diagnostics by Test - Percentage Breakdown of Value Sales for Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests for the Years 2015, 2025 & 2030
• EUROPE
  • Respiratory Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
  • TABLE 74: Europe Recent Past, Current & Future Analysis for Respiratory Diagnostics by Disease - Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 75: Europe Historic Review for Respiratory Diagnostics by Disease - Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 76: Europe 15-Year Perspective for Respiratory Diagnostics by Disease - Percentage Breakdown of Value Sales for Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases for the Years 2015, 2025 & 2030
  • TABLE 77: Europe Recent Past, Current & Future Analysis for Respiratory Diagnostics by Offering - Instruments & Devices, Kits & Reagents and Services & Software - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 78: Europe Historic Review for Respiratory Diagnostics by Offering - Instruments & Devices, Kits & Reagents and Services & Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 79: Europe 15-Year Perspective for Respiratory Diagnostics by Offering - Percentage Breakdown of Value Sales for Instruments & Devices, Kits & Reagents and Services & Software for the Years 2015, 2025 & 2030
  • TABLE 80: Europe Recent Past, Current & Future Analysis for Respiratory Diagnostics by Test - Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 81: Europe Historic Review for Respiratory Diagnostics by Test - Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 82: Europe 15-Year Perspective for Respiratory Diagnostics by Test - Percentage Breakdown of Value Sales for Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests for the Years 2015, 2025 & 2030
  • TABLE 83: Europe Recent Past, Current & Future Analysis for Respiratory Diagnostics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 84: Europe Historic Review for Respiratory Diagnostics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 85: Europe 15-Year Perspective for Respiratory Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
• FRANCE
  • Respiratory Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
  • TABLE 86: France Recent Past, Current & Future Analysis for Respiratory Diagnostics by Disease - Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 87: France Historic Review for Respiratory Diagnostics by Disease - Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 88: France 15-Year Perspective for Respiratory Diagnostics by Disease - Percentage Breakdown of Value Sales for Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases for the Years 2015, 2025 & 2030
  • TABLE 89: France Recent Past, Current & Future Analysis for Respiratory Diagnostics by Offering - Instruments & Devices, Kits & Reagents and Services & Software - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 90: France Historic Review for Respiratory Diagnostics by Offering - Instruments & Devices, Kits & Reagents and Services & Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 91: France 15-Year Perspective for Respiratory Diagnostics by Offering - Percentage Breakdown of Value Sales for Instruments & Devices, Kits & Reagents and Services & Software for the Years 2015, 2025 & 2030
  • TABLE 92: France Recent Past, Current & Future Analysis for Respiratory Diagnostics by Test - Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 93: France Historic Review for Respiratory Diagnostics by Test - Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 94: France 15-Year Perspective for Respiratory Diagnostics by Test - Percentage Breakdown of Value Sales for Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests for the Years 2015, 2025 & 2030
• GERMANY
  • Respiratory Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
  • TABLE 95: Germany Recent Past, Current & Future Analysis for Respiratory Diagnostics by Disease - Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 96: Germany Historic Review for Respiratory Diagnostics by Disease - Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 97: Germany 15-Year Perspective for Respiratory Diagnostics by Disease - Percentage Breakdown of Value Sales for Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases for the Years 2015, 2025 & 2030
  • TABLE 98: Germany Recent Past, Current & Future Analysis for Respiratory Diagnostics by Offering - Instruments & Devices, Kits & Reagents and Services & Software - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 99: Germany Historic Review for Respiratory Diagnostics by Offering - Instruments & Devices, Kits & Reagents and Services & Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 100: Germany 15-Year Perspective for Respiratory Diagnostics by Offering - Percentage Breakdown of Value Sales for Instruments & Devices, Kits & Reagents and Services & Software for the Years 2015, 2025 & 2030
  • TABLE 101: Germany Recent Past, Current & Future Analysis for Respiratory Diagnostics by Test - Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 102: Germany Historic Review for Respiratory Diagnostics by Test - Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 103: Germany 15-Year Perspective for Respiratory Diagnostics by Test - Percentage Breakdown of Value Sales for Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests for the Years 2015, 2025 & 2030
• ITALY
  • TABLE 104: Italy Recent Past, Current & Future Analysis for Respiratory Diagnostics by Disease - Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 105: Italy Historic Review for Respiratory Diagnostics by Disease - Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 106: Italy 15-Year Perspective for Respiratory Diagnostics by Disease - Percentage Breakdown of Value Sales for Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases for the Years 2015, 2025 & 2030
  • TABLE 107: Italy Recent Past, Current & Future Analysis for Respiratory Diagnostics by Offering - Instruments & Devices, Kits & Reagents and Services & Software - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 108: Italy Historic Review for Respiratory Diagnostics by Offering - Instruments & Devices, Kits & Reagents and Services & Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 109: Italy 15-Year Perspective for Respiratory Diagnostics by Offering - Percentage Breakdown of Value Sales for Instruments & Devices, Kits & Reagents and Services & Software for the Years 2015, 2025 & 2030
  • TABLE 110: Italy Recent Past, Current & Future Analysis for Respiratory Diagnostics by Test - Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 111: Italy Historic Review for Respiratory Diagnostics by Test - Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 112: Italy 15-Year Perspective for Respiratory Diagnostics by Test - Percentage Breakdown of Value Sales for Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests for the Years 2015, 2025 & 2030
• UNITED KINGDOM
  • Respiratory Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
  • TABLE 113: UK Recent Past, Current & Future Analysis for Respiratory Diagnostics by Disease - Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 114: UK Historic Review for Respiratory Diagnostics by Disease - Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 115: UK 15-Year Perspective for Respiratory Diagnostics by Disease - Percentage Breakdown of Value Sales for Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases for the Years 2015, 2025 & 2030
  • TABLE 116: UK Recent Past, Current & Future Analysis for Respiratory Diagnostics by Offering - Instruments & Devices, Kits & Reagents and Services & Software - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 117: UK Historic Review for Respiratory Diagnostics by Offering - Instruments & Devices, Kits & Reagents and Services & Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 118: UK 15-Year Perspective for Respiratory Diagnostics by Offering - Percentage Breakdown of Value Sales for Instruments & Devices, Kits & Reagents and Services & Software for the Years 2015, 2025 & 2030
  • TABLE 119: UK Recent Past, Current & Future Analysis for Respiratory Diagnostics by Test - Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 120: UK Historic Review for Respiratory Diagnostics by Test - Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 121: UK 15-Year Perspective for Respiratory Diagnostics by Test - Percentage Breakdown of Value Sales for Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests for the Years 2015, 2025 & 2030
• SPAIN
  • TABLE 122: Spain Recent Past, Current & Future Analysis for Respiratory Diagnostics by Disease - Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 123: Spain Historic Review for Respiratory Diagnostics by Disease - Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 124: Spain 15-Year Perspective for Respiratory Diagnostics by Disease - Percentage Breakdown of Value Sales for Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases for the Years 2015, 2025 & 2030
  • TABLE 125: Spain Recent Past, Current & Future Analysis for Respiratory Diagnostics by Offering - Instruments & Devices, Kits & Reagents and Services & Software - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 126: Spain Historic Review for Respiratory Diagnostics by Offering - Instruments & Devices, Kits & Reagents and Services & Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 127: Spain 15-Year Perspective for Respiratory Diagnostics by Offering - Percentage Breakdown of Value Sales for Instruments & Devices, Kits & Reagents and Services & Software for the Years 2015, 2025 & 2030
  • TABLE 128: Spain Recent Past, Current & Future Analysis for Respiratory Diagnostics by Test - Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 129: Spain Historic Review for Respiratory Diagnostics by Test - Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 130: Spain 15-Year Perspective for Respiratory Diagnostics by Test - Percentage Breakdown of Value Sales for Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests for the Years 2015, 2025 & 2030
• RUSSIA
  • TABLE 131: Russia Recent Past, Current & Future Analysis for Respiratory Diagnostics by Disease - Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 132: Russia Historic Review for Respiratory Diagnostics by Disease - Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 133: Russia 15-Year Perspective for Respiratory Diagnostics by Disease - Percentage Breakdown of Value Sales for Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases for the Years 2015, 2025 & 2030
  • TABLE 134: Russia Recent Past, Current & Future Analysis for Respiratory Diagnostics by Offering - Instruments & Devices, Kits & Reagents and Services & Software - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 135: Russia Historic Review for Respiratory Diagnostics by Offering - Instruments & Devices, Kits & Reagents and Services & Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 136: Russia 15-Year Perspective for Respiratory Diagnostics by Offering - Percentage Breakdown of Value Sales for Instruments & Devices, Kits & Reagents and Services & Software for the Years 2015, 2025 & 2030
  • TABLE 137: Russia Recent Past, Current & Future Analysis for Respiratory Diagnostics by Test - Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 138: Russia Historic Review for Respiratory Diagnostics by Test - Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 139: Russia 15-Year Perspective for Respiratory Diagnostics by Test - Percentage Breakdown of Value Sales for Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests for the Years 2015, 2025 & 2030
• REST OF EUROPE
  • TABLE 140: Rest of Europe Recent Past, Current & Future Analysis for Respiratory Diagnostics by Disease - Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 141: Rest of Europe Historic Review for Respiratory Diagnostics by Disease - Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 142: Rest of Europe 15-Year Perspective for Respiratory Diagnostics by Disease - Percentage Breakdown of Value Sales for Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases for the Years 2015, 2025 & 2030
  • TABLE 143: Rest of Europe Recent Past, Current & Future Analysis for Respiratory Diagnostics by Offering - Instruments & Devices, Kits & Reagents and Services & Software - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 144: Rest of Europe Historic Review for Respiratory Diagnostics by Offering - Instruments & Devices, Kits & Reagents and Services & Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 145: Rest of Europe 15-Year Perspective for Respiratory Diagnostics by Offering - Percentage Breakdown of Value Sales for Instruments & Devices, Kits & Reagents and Services & Software for the Years 2015, 2025 & 2030
  • TABLE 146: Rest of Europe Recent Past, Current & Future Analysis for Respiratory Diagnostics by Test - Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 147: Rest of Europe Historic Review for Respiratory Diagnostics by Test - Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 148: Rest of Europe 15-Year Perspective for Respiratory Diagnostics by Test - Percentage Breakdown of Value Sales for Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests for the Years 2015, 2025 & 2030
• ASIA-PACIFIC
  • Respiratory Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
  • TABLE 149: Asia-Pacific Recent Past, Current & Future Analysis for Respiratory Diagnostics by Disease - Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 150: Asia-Pacific Historic Review for Respiratory Diagnostics by Disease - Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 151: Asia-Pacific 15-Year Perspective for Respiratory Diagnostics by Disease - Percentage Breakdown of Value Sales for Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases for the Years 2015, 2025 & 2030
  • TABLE 152: Asia-Pacific Recent Past, Current & Future Analysis for Respiratory Diagnostics by Offering - Instruments & Devices, Kits & Reagents and Services & Software - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 153: Asia-Pacific Historic Review for Respiratory Diagnostics by Offering - Instruments & Devices, Kits & Reagents and Services & Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 154: Asia-Pacific 15-Year Perspective for Respiratory Diagnostics by Offering - Percentage Breakdown of Value Sales for Instruments & Devices, Kits & Reagents and Services & Software for the Years 2015, 2025 & 2030
  • TABLE 155: Asia-Pacific Recent Past, Current & Future Analysis for Respiratory Diagnostics by Test - Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 156: Asia-Pacific Historic Review for Respiratory Diagnostics by Test - Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 157: Asia-Pacific 15-Year Perspective for Respiratory Diagnostics by Test - Percentage Breakdown of Value Sales for Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests for the Years 2015, 2025 & 2030
  • TABLE 158: Asia-Pacific Recent Past, Current & Future Analysis for Respiratory Diagnostics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 159: Asia-Pacific Historic Review for Respiratory Diagnostics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 160: Asia-Pacific 15-Year Perspective for Respiratory Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
• AUSTRALIA
  • Respiratory Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
  • TABLE 161: Australia Recent Past, Current & Future Analysis for Respiratory Diagnostics by Disease - Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 162: Australia Historic Review for Respiratory Diagnostics by Disease - Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 163: Australia 15-Year Perspective for Respiratory Diagnostics by Disease - Percentage Breakdown of Value Sales for Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases for the Years 2015, 2025 & 2030
  • TABLE 164: Australia Recent Past, Current & Future Analysis for Respiratory Diagnostics by Offering - Instruments & Devices, Kits & Reagents and Services & Software - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 165: Australia Historic Review for Respiratory Diagnostics by Offering - Instruments & Devices, Kits & Reagents and Services & Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 166: Australia 15-Year Perspective for Respiratory Diagnostics by Offering - Percentage Breakdown of Value Sales for Instruments & Devices, Kits & Reagents and Services & Software for the Years 2015, 2025 & 2030
  • TABLE 167: Australia Recent Past, Current & Future Analysis for Respiratory Diagnostics by Test - Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 168: Australia Historic Review for Respiratory Diagnostics by Test - Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 169: Australia 15-Year Perspective for Respiratory Diagnostics by Test - Percentage Breakdown of Value Sales for Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests for the Years 2015, 2025 & 2030
• INDIA
  • Respiratory Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
  • TABLE 170: India Recent Past, Current & Future Analysis for Respiratory Diagnostics by Disease - Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 171: India Historic Review for Respiratory Diagnostics by Disease - Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 172: India 15-Year Perspective for Respiratory Diagnostics by Disease - Percentage Breakdown of Value Sales for Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases for the Years 2015, 2025 & 2030
  • TABLE 173: India Recent Past, Current & Future Analysis for Respiratory Diagnostics by Offering - Instruments & Devices, Kits & Reagents and Services & Software - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 174: India Historic Review for Respiratory Diagnostics by Offering - Instruments & Devices, Kits & Reagents and Services & Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 175: India 15-Year Perspective for Respiratory Diagnostics by Offering - Percentage Breakdown of Value Sales for Instruments & Devices, Kits & Reagents and Services & Software for the Years 2015, 2025 & 2030
  • TABLE 176: India Recent Past, Current & Future Analysis for Respiratory Diagnostics by Test - Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 177: India Historic Review for Respiratory Diagnostics by Test - Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 178: India 15-Year Perspective for Respiratory Diagnostics by Test - Percentage Breakdown of Value Sales for Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests for the Years 2015, 2025 & 2030
• SOUTH KOREA
  • TABLE 179: South Korea Recent Past, Current & Future Analysis for Respiratory Diagnostics by Disease - Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 180: South Korea Historic Review for Respiratory Diagnostics by Disease - Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 181: South Korea 15-Year Perspective for Respiratory Diagnostics by Disease - Percentage Breakdown of Value Sales for Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases for the Years 2015, 2025 & 2030
  • TABLE 182: South Korea Recent Past, Current & Future Analysis for Respiratory Diagnostics by Offering - Instruments & Devices, Kits & Reagents and Services & Software - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 183: South Korea Historic Review for Respiratory Diagnostics by Offering - Instruments & Devices, Kits & Reagents and Services & Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 184: South Korea 15-Year Perspective for Respiratory Diagnostics by Offering - Percentage Breakdown of Value Sales for Instruments & Devices, Kits & Reagents and Services & Software for the Years 2015, 2025 & 2030
  • TABLE 185: South Korea Recent Past, Current & Future Analysis for Respiratory Diagnostics by Test - Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 186: South Korea Historic Review for Respiratory Diagnostics by Test - Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 187: South Korea 15-Year Perspective for Respiratory Diagnostics by Test - Percentage Breakdown of Value Sales for Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests for the Years 2015, 2025 & 2030
• REST OF ASIA-PACIFIC
  • TABLE 188: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Respiratory Diagnostics by Disease - Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 189: Rest of Asia-Pacific Historic Review for Respiratory Diagnostics by Disease - Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 190: Rest of Asia-Pacific 15-Year Perspective for Respiratory Diagnostics by Disease - Percentage Breakdown of Value Sales for Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases for the Years 2015, 2025 & 2030
  • TABLE 191: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Respiratory Diagnostics by Offering - Instruments & Devices, Kits & Reagents and Services & Software - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 192: Rest of Asia-Pacific Historic Review for Respiratory Diagnostics by Offering - Instruments & Devices, Kits & Reagents and Services & Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 193: Rest of Asia-Pacific 15-Year Perspective for Respiratory Diagnostics by Offering - Percentage Breakdown of Value Sales for Instruments & Devices, Kits & Reagents and Services & Software for the Years 2015, 2025 & 2030
  • TABLE 194: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Respiratory Diagnostics by Test - Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 195: Rest of Asia-Pacific Historic Review for Respiratory Diagnostics by Test - Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 196: Rest of Asia-Pacific 15-Year Perspective for Respiratory Diagnostics by Test - Percentage Breakdown of Value Sales for Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests for the Years 2015, 2025 & 2030
• LATIN AMERICA
  • Respiratory Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
  • TABLE 197: Latin America Recent Past, Current & Future Analysis for Respiratory Diagnostics by Disease - Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 198: Latin America Historic Review for Respiratory Diagnostics by Disease - Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 199: Latin America 15-Year Perspective for Respiratory Diagnostics by Disease - Percentage Breakdown of Value Sales for Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases for the Years 2015, 2025 & 2030
  • TABLE 200: Latin America Recent Past, Current & Future Analysis for Respiratory Diagnostics by Offering - Instruments & Devices, Kits & Reagents and Services & Software - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 201: Latin America Historic Review for Respiratory Diagnostics by Offering - Instruments & Devices, Kits & Reagents and Services & Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 202: Latin America 15-Year Perspective for Respiratory Diagnostics by Offering - Percentage Breakdown of Value Sales for Instruments & Devices, Kits & Reagents and Services & Software for the Years 2015, 2025 & 2030
  • TABLE 203: Latin America Recent Past, Current & Future Analysis for Respiratory Diagnostics by Test - Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 204: Latin America Historic Review for Respiratory Diagnostics by Test - Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 205: Latin America 15-Year Perspective for Respiratory Diagnostics by Test - Percentage Breakdown of Value Sales for Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests for the Years 2015, 2025 & 2030
  • TABLE 206: Latin America Recent Past, Current & Future Analysis for Respiratory Diagnostics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 207: Latin America Historic Review for Respiratory Diagnostics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 208: Latin America 15-Year Perspective for Respiratory Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
• ARGENTINA
  • TABLE 209: Argentina Recent Past, Current & Future Analysis for Respiratory Diagnostics by Disease - Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 210: Argentina Historic Review for Respiratory Diagnostics by Disease - Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 211: Argentina 15-Year Perspective for Respiratory Diagnostics by Disease - Percentage Breakdown of Value Sales for Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases for the Years 2015, 2025 & 2030
  • TABLE 212: Argentina Recent Past, Current & Future Analysis for Respiratory Diagnostics by Offering - Instruments & Devices, Kits & Reagents and Services & Software - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 213: Argentina Historic Review for Respiratory Diagnostics by Offering - Instruments & Devices, Kits & Reagents and Services & Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 214: Argentina 15-Year Perspective for Respiratory Diagnostics by Offering - Percentage Breakdown of Value Sales for Instruments & Devices, Kits & Reagents and Services & Software for the Years 2015, 2025 & 2030
  • TABLE 215: Argentina Recent Past, Current & Future Analysis for Respiratory Diagnostics by Test - Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 216: Argentina Historic Review for Respiratory Diagnostics by Test - Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 217: Argentina 15-Year Perspective for Respiratory Diagnostics by Test - Percentage Breakdown of Value Sales for Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests for the Years 2015, 2025 & 2030
• BRAZIL
  • TABLE 218: Brazil Recent Past, Current & Future Analysis for Respiratory Diagnostics by Disease - Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 219: Brazil Historic Review for Respiratory Diagnostics by Disease - Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 220: Brazil 15-Year Perspective for Respiratory Diagnostics by Disease - Percentage Breakdown of Value Sales for Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases for the Years 2015, 2025 & 2030
  • TABLE 221: Brazil Recent Past, Current & Future Analysis for Respiratory Diagnostics by Offering - Instruments & Devices, Kits & Reagents and Services & Software - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 222: Brazil Historic Review for Respiratory Diagnostics by Offering - Instruments & Devices, Kits & Reagents and Services & Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 223: Brazil 15-Year Perspective for Respiratory Diagnostics by Offering - Percentage Breakdown of Value Sales for Instruments & Devices, Kits & Reagents and Services & Software for the Years 2015, 2025 & 2030
  • TABLE 224: Brazil Recent Past, Current & Future Analysis for Respiratory Diagnostics by Test - Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 225: Brazil Historic Review for Respiratory Diagnostics by Test - Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 226: Brazil 15-Year Perspective for Respiratory Diagnostics by Test - Percentage Breakdown of Value Sales for Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests for the Years 2015, 2025 & 2030
• MEXICO
  • TABLE 227: Mexico Recent Past, Current & Future Analysis for Respiratory Diagnostics by Disease - Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 228: Mexico Historic Review for Respiratory Diagnostics by Disease - Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 229: Mexico 15-Year Perspective for Respiratory Diagnostics by Disease - Percentage Breakdown of Value Sales for Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases for the Years 2015, 2025 & 2030
  • TABLE 230: Mexico Recent Past, Current & Future Analysis for Respiratory Diagnostics by Offering - Instruments & Devices, Kits & Reagents and Services & Software - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 231: Mexico Historic Review for Respiratory Diagnostics by Offering - Instruments & Devices, Kits & Reagents and Services & Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 232: Mexico 15-Year Perspective for Respiratory Diagnostics by Offering - Percentage Breakdown of Value Sales for Instruments & Devices, Kits & Reagents and Services & Software for the Years 2015, 2025 & 2030
  • TABLE 233: Mexico Recent Past, Current & Future Analysis for Respiratory Diagnostics by Test - Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 234: Mexico Historic Review for Respiratory Diagnostics by Test - Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 235: Mexico 15-Year Perspective for Respiratory Diagnostics by Test - Percentage Breakdown of Value Sales for Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests for the Years 2015, 2025 & 2030
• REST OF LATIN AMERICA
  • TABLE 236: Rest of Latin America Recent Past, Current & Future Analysis for Respiratory Diagnostics by Disease - Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 237: Rest of Latin America Historic Review for Respiratory Diagnostics by Disease - Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 238: Rest of Latin America 15-Year Perspective for Respiratory Diagnostics by Disease - Percentage Breakdown of Value Sales for Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases for the Years 2015, 2025 & 2030
  • TABLE 239: Rest of Latin America Recent Past, Current & Future Analysis for Respiratory Diagnostics by Offering - Instruments & Devices, Kits & Reagents and Services & Software - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 240: Rest of Latin America Historic Review for Respiratory Diagnostics by Offering - Instruments & Devices, Kits & Reagents and Services & Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 241: Rest of Latin America 15-Year Perspective for Respiratory Diagnostics by Offering - Percentage Breakdown of Value Sales for Instruments & Devices, Kits & Reagents and Services & Software for the Years 2015, 2025 & 2030
  • TABLE 242: Rest of Latin America Recent Past, Current & Future Analysis for Respiratory Diagnostics by Test - Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 243: Rest of Latin America Historic Review for Respiratory Diagnostics by Test - Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 244: Rest of Latin America 15-Year Perspective for Respiratory Diagnostics by Test - Percentage Breakdown of Value Sales for Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests for the Years 2015, 2025 & 2030
• MIDDLE EAST
  • Respiratory Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
  • TABLE 245: Middle East Recent Past, Current & Future Analysis for Respiratory Diagnostics by Disease - Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 246: Middle East Historic Review for Respiratory Diagnostics by Disease - Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 247: Middle East 15-Year Perspective for Respiratory Diagnostics by Disease - Percentage Breakdown of Value Sales for Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases for the Years 2015, 2025 & 2030
  • TABLE 248: Middle East Recent Past, Current & Future Analysis for Respiratory Diagnostics by Offering - Instruments & Devices, Kits & Reagents and Services & Software - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 249: Middle East Historic Review for Respiratory Diagnostics by Offering - Instruments & Devices, Kits & Reagents and Services & Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 250: Middle East 15-Year Perspective for Respiratory Diagnostics by Offering - Percentage Breakdown of Value Sales for Instruments & Devices, Kits & Reagents and Services & Software for the Years 2015, 2025 & 2030
  • TABLE 251: Middle East Recent Past, Current & Future Analysis for Respiratory Diagnostics by Test - Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 252: Middle East Historic Review for Respiratory Diagnostics by Test - Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 253: Middle East 15-Year Perspective for Respiratory Diagnostics by Test - Percentage Breakdown of Value Sales for Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests for the Years 2015, 2025 & 2030
  • TABLE 254: Middle East Recent Past, Current & Future Analysis for Respiratory Diagnostics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 255: Middle East Historic Review for Respiratory Diagnostics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 256: Middle East 15-Year Perspective for Respiratory Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
• IRAN
  • TABLE 257: Iran Recent Past, Current & Future Analysis for Respiratory Diagnostics by Disease - Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 258: Iran Historic Review for Respiratory Diagnostics by Disease - Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 259: Iran 15-Year Perspective for Respiratory Diagnostics by Disease - Percentage Breakdown of Value Sales for Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases for the Years 2015, 2025 & 2030
  • TABLE 260: Iran Recent Past, Current & Future Analysis for Respiratory Diagnostics by Offering - Instruments & Devices, Kits & Reagents and Services & Software - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 261: Iran Historic Review for Respiratory Diagnostics by Offering - Instruments & Devices, Kits & Reagents and Services & Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 262: Iran 15-Year Perspective for Respiratory Diagnostics by Offering - Percentage Breakdown of Value Sales for Instruments & Devices, Kits & Reagents and Services & Software for the Years 2015, 2025 & 2030
  • TABLE 263: Iran Recent Past, Current & Future Analysis for Respiratory Diagnostics by Test - Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 264: Iran Historic Review for Respiratory Diagnostics by Test - Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 265: Iran 15-Year Perspective for Respiratory Diagnostics by Test - Percentage Breakdown of Value Sales for Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests for the Years 2015, 2025 & 2030
• ISRAEL
  • TABLE 266: Israel Recent Past, Current & Future Analysis for Respiratory Diagnostics by Disease - Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 267: Israel Historic Review for Respiratory Diagnostics by Disease - Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 268: Israel 15-Year Perspective for Respiratory Diagnostics by Disease - Percentage Breakdown of Value Sales for Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases for the Years 2015, 2025 & 2030
  • TABLE 269: Israel Recent Past, Current & Future Analysis for Respiratory Diagnostics by Offering - Instruments & Devices, Kits & Reagents and Services & Software - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 270: Israel Historic Review for Respiratory Diagnostics by Offering - Instruments & Devices, Kits & Reagents and Services & Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 271: Israel 15-Year Perspective for Respiratory Diagnostics by Offering - Percentage Breakdown of Value Sales for Instruments & Devices, Kits & Reagents and Services & Software for the Years 2015, 2025 & 2030
  • TABLE 272: Israel Recent Past, Current & Future Analysis for Respiratory Diagnostics by Test - Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 273: Israel Historic Review for Respiratory Diagnostics by Test - Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 274: Israel 15-Year Perspective for Respiratory Diagnostics by Test - Percentage Breakdown of Value Sales for Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests for the Years 2015, 2025 & 2030
• SAUDI ARABIA
  • TABLE 275: Saudi Arabia Recent Past, Current & Future Analysis for Respiratory Diagnostics by Disease - Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 276: Saudi Arabia Historic Review for Respiratory Diagnostics by Disease - Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 277: Saudi Arabia 15-Year Perspective for Respiratory Diagnostics by Disease - Percentage Breakdown of Value Sales for Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases for the Years 2015, 2025 & 2030
  • TABLE 278: Saudi Arabia Recent Past, Current & Future Analysis for Respiratory Diagnostics by Offering - Instruments & Devices, Kits & Reagents and Services & Software - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 279: Saudi Arabia Historic Review for Respiratory Diagnostics by Offering - Instruments & Devices, Kits & Reagents and Services & Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 280: Saudi Arabia 15-Year Perspective for Respiratory Diagnostics by Offering - Percentage Breakdown of Value Sales for Instruments & Devices, Kits & Reagents and Services & Software for the Years 2015, 2025 & 2030
  • TABLE 281: Saudi Arabia Recent Past, Current & Future Analysis for Respiratory Diagnostics by Test - Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 282: Saudi Arabia Historic Review for Respiratory Diagnostics by Test - Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 283: Saudi Arabia 15-Year Perspective for Respiratory Diagnostics by Test - Percentage Breakdown of Value Sales for Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests for the Years 2015, 2025 & 2030
• UNITED ARAB EMIRATES
  • TABLE 284: UAE Recent Past, Current & Future Analysis for Respiratory Diagnostics by Disease - Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 285: UAE Historic Review for Respiratory Diagnostics by Disease - Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 286: UAE 15-Year Perspective for Respiratory Diagnostics by Disease - Percentage Breakdown of Value Sales for Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases for the Years 2015, 2025 & 2030
  • TABLE 287: UAE Recent Past, Current & Future Analysis for Respiratory Diagnostics by Offering - Instruments & Devices, Kits & Reagents and Services & Software - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 288: UAE Historic Review for Respiratory Diagnostics by Offering - Instruments & Devices, Kits & Reagents and Services & Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 289: UAE 15-Year Perspective for Respiratory Diagnostics by Offering - Percentage Breakdown of Value Sales for Instruments & Devices, Kits & Reagents and Services & Software for the Years 2015, 2025 & 2030
  • TABLE 290: UAE Recent Past, Current & Future Analysis for Respiratory Diagnostics by Test - Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 291: UAE Historic Review for Respiratory Diagnostics by Test - Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 292: UAE 15-Year Perspective for Respiratory Diagnostics by Test - Percentage Breakdown of Value Sales for Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests for the Years 2015, 2025 & 2030
• REST OF MIDDLE EAST
  • TABLE 293: Rest of Middle East Recent Past, Current & Future Analysis for Respiratory Diagnostics by Disease - Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 294: Rest of Middle East Historic Review for Respiratory Diagnostics by Disease - Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 295: Rest of Middle East 15-Year Perspective for Respiratory Diagnostics by Disease - Percentage Breakdown of Value Sales for Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases for the Years 2015, 2025 & 2030
  • TABLE 296: Rest of Middle East Recent Past, Current & Future Analysis for Respiratory Diagnostics by Offering - Instruments & Devices, Kits & Reagents and Services & Software - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 297: Rest of Middle East Historic Review for Respiratory Diagnostics by Offering - Instruments & Devices, Kits & Reagents and Services & Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 298: Rest of Middle East 15-Year Perspective for Respiratory Diagnostics by Offering - Percentage Breakdown of Value Sales for Instruments & Devices, Kits & Reagents and Services & Software for the Years 2015, 2025 & 2030
  • TABLE 299: Rest of Middle East Recent Past, Current & Future Analysis for Respiratory Diagnostics by Test - Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 300: Rest of Middle East Historic Review for Respiratory Diagnostics by Test - Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 301: Rest of Middle East 15-Year Perspective for Respiratory Diagnostics by Test - Percentage Breakdown of Value Sales for Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests for the Years 2015, 2025 & 2030
• AFRICA
  • Respiratory Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
  • TABLE 302: Africa Recent Past, Current & Future Analysis for Respiratory Diagnostics by Disease - Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 303: Africa Historic Review for Respiratory Diagnostics by Disease - Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 304: Africa 15-Year Perspective for Respiratory Diagnostics by Disease - Percentage Breakdown of Value Sales for Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases for the Years 2015, 2025 & 2030
  • TABLE 305: Africa Recent Past, Current & Future Analysis for Respiratory Diagnostics by Offering - Instruments & Devices, Kits & Reagents and Services & Software - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 306: Africa Historic Review for Respiratory Diagnostics by Offering - Instruments & Devices, Kits & Reagents and Services & Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 307: Africa 15-Year Perspective for Respiratory Diagnostics by Offering - Percentage Breakdown of Value Sales for Instruments & Devices, Kits & Reagents and Services & Software for the Years 2015, 2025 & 2030
  • TABLE 308: Africa Recent Past, Current & Future Analysis for Respiratory Diagnostics by Test - Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 309: Africa Historic Review for Respiratory Diagnostics by Test - Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 310: Africa 15-Year Perspective for Respiratory Diagnostics by Test - Percentage Breakdown of Value Sales for Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests for the Years 2015, 2025 & 2030

IV. COMPETITION